These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 8428341)

  • 21. Loss of heterozygosity on chromosome 10, 13q(Rb), 17p, and p53 gene mutations in human brain gliomas.
    Lee SH; Kim JH; Rhee CH; Kang YS; Lee JH; Hong SI; Choi KS
    J Korean Med Sci; 1995 Dec; 10(6):442-8. PubMed ID: 8924230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder.
    Gonzalez-Zulueta M; Shibata A; Ohneseit PF; Spruck CH; Busch C; Shamaa M; El-Baz M; Nichols PW; Gonzalgo ML; Elbaz M [corrected to El-Baz M]
    J Natl Cancer Inst; 1995 Sep; 87(18):1383-93. PubMed ID: 7658499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular biology of prostate cancer.
    Isaacs WB; Bova GS; Morton RA; Bussemakers MJ; Brooks JD; Ewing CM
    Semin Oncol; 1994 Oct; 21(5):514-21. PubMed ID: 7939745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allelic loss of chromosomes 16q and 10q in human prostate cancer.
    Carter BS; Ewing CM; Ward WS; Treiger BF; Aalders TW; Schalken JA; Epstein JI; Isaacs WB
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8751-5. PubMed ID: 1978938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate.
    Tamboli P; Amin MB; Xu HJ; Linden MD
    Mod Pathol; 1998 Mar; 11(3):247-52. PubMed ID: 9521470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice.
    Pasquinelli C; Bhavani K; Chisari FV
    Cancer Res; 1992 May; 52(10):2823-9. PubMed ID: 1316229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two distinct commonly deleted regions on chromosome 13q suggest involvement of BRCA2 and retinoblastoma genes in sporadic breast carcinomas.
    Tsukamoto K; Ito N; Yoshimoto M; Iwase T; Tada T; Kasumi F; Nakamura Y; Emi M
    Cancer; 1996 Nov; 78(9):1929-34. PubMed ID: 8909313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor suppressor activity of RB and p53 genes in human breast carcinoma cells.
    Wang NP; To H; Lee WH; Lee EY
    Oncogene; 1993 Feb; 8(2):279-88. PubMed ID: 8426737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric molecular oncology. Past as prologue to the future.
    Knudson AG
    Cancer; 1993 May; 71(10 Suppl):3320-4. PubMed ID: 8490875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tumor suppressor genes: mutations in RB and p53 genes are significant carcinogenic factors].
    Wiman KG
    Lakartidningen; 1992 Sep; 89(39):3169-74. PubMed ID: 1405928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor suppressor genes involved in metastasis of lung and colorectal carcinomas.
    Yokota J; Ookawa K; Nishikawa R; Sameshima Y
    Princess Takamatsu Symp; 1991; 22():71-6. PubMed ID: 1844253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The molecular genetics of retinoblastoma.
    Goodrich DW; Lee WH
    Cancer Surv; 1990; 9(3):529-54. PubMed ID: 2101724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Complex characteristics of the alterations of oncogenes HER-2/ERBB-2, HER-1/ERBB-1, HRAS-1, C-MYC and antioncogenes p53, RB1, as well as deletions of loci of chromosome 17 in colon carcinoma].
    Kniazev PG; Imianitov EN; Chernitsa OI; Nikiforova IF; Babenko VI; Bruderliaĭn S; Plutalo OV; Kuz'min AI; Kaboev OK; Berlin IuA
    Mol Biol (Mosk); 1992; 26(5):1134-47. PubMed ID: 1470178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
    Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
    Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Identification of oncogenes and anti-oncogenes].
    Thomas G
    Pathol Biol (Paris); 1995 Mar; 43(3):143-9. PubMed ID: 7675540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of allelic loss and gain in prostate cancer.
    Bova GS; Isaacs WB
    World J Urol; 1996; 14(5):338-46. PubMed ID: 8912474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles.
    Isaacs WB; Carter BS; Ewing CM
    Cancer Res; 1991 Sep; 51(17):4716-20. PubMed ID: 1873816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tumor suppressor genes].
    Kohno T; Yokota J
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1265-73. PubMed ID: 8392829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of two distinct deleted regions on chromosome 13 in prostate cancer.
    Li C; Larsson C; Futreal A; Lancaster J; Phelan C; Aspenblad U; Sundelin B; Liu Y; Ekman P; Auer G; Bergerheim US
    Oncogene; 1998 Jan; 16(4):481-7. PubMed ID: 9484837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53.
    Ambros RA; Vigna PA; Figge J; Kallakury BV; Mastrangelo A; Eastman AY; Malfetano J; Figge HL; Ross JS
    Cancer; 1994 Mar; 73(6):1686-92. PubMed ID: 8156496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.